Beta Bionics, Inc.
$243.6K 6,506 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Olympus Medical Systems Corporation
Olympus Medical Systems Corporation reported $242,809.09 across General Payments, Research, and Ownership to 264 physicians and teaching hospitals across 264 transactions.
- $242.8K Above-median payer
- All-tracks total
- 264 Above-median volume
- Transactions
- 264 Above-median reach
- Recipients
- −$57.4K
- General Payments vs PY2023
Olympus Medical Systems Corporation reported $242,809.09 across all CMS Open Payments tracks (General + Research + Ownership) to 264 physicians and teaching hospitals in Program Year 2024 - ranking #950 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $242,809.09, averaging $919.73 per recipient.
Olympus Medical Systems Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
12/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer olympus-medical-systems-corporation Olympus Medical Systems Corporation
$242.8K · #950/1,925 · 0.0% industry · PY2024
- TOT $242.8K
- RANK #950
- SHARE 0.0%
- TXN 264
- RCP 264
- CAT 3
- GEN $242.8K
- ΔGEN −$57.4K
- TOP1 10.1%
- PY 2024
Volume peers
Nearest volume peer: Beta Bionics, Inc. ($243.6K)
Olympus Medical Systems Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Olympus Medical Systems Corporation's CMS-reported General Payments decreased by $57.4K (−19.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: OLYMPUS MEDICAL SYSTEMS CORPORATIONPY2024: Olympus Medical Systems Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $300,209.45
- PY2024
- $242,809.09
What the Data Shows for Olympus Medical Systems Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Olympus Medical Systems Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $240.2K across 209 transactions, 98.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Olympus Medical Systems Corporation made 3 types of general payments. "Consulting Fee" is the largest category at $240.2K, 98.9% of General Payments.
How Olympus Medical Systems Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $240.2K | 209 | 98.9% |
| Travel and Lodging | $1.7K | 36 | 0.7% |
| Food and Beverage | $935.17 | 19 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $54,208.41 (22.3%) of $242,809.09 in this company's General Payments records across 95 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Olympus Medical Systems Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Rahul Pannala
$24,590.78 across 5 reported transactions
- 2
Catherine L Oberg
$7,828.86 across 9 reported transactions
- 3
Hiroyuki Aihara
$7,477.55 across 10 reported transactions
- 4
Roberto F Casal
$7,161.22 across 6 reported transactions
- 5
Michael Shawn Machuzak
$7,150.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Olympus Medical Systems Corporation ranks #950 of 1,925 by total payments (top 49% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,509 of 1,838 by HHI (bottom 18% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Curonix LLC : $754.8K total payments, HHI 254
- Argon Medical Devices, Inc. : $147.3K total payments, HHI 254
- Averitas Pharma Inc. : $1.5M total payments, HHI 253
- Ambu A/S : $181.1K total payments, HHI 252
- Ivoclar Vivadent, Inc. : $280.4K total payments, HHI 251
- MDD US Operations, LLC : $1.7M total payments, HHI 249
- Olympus Medical Systems Corporation (this company) : $242.8K total payments, HHI 248
- Verrica Pharmaceuticals Inc. : $1.1M total payments, HHI 248
- Recordati_rare_diseases_inc. : $714.2K total payments, HHI 247
- Prism Medical : $34.0K total payments, HHI 247
- Medtronic, Inc. : $117.7M total payments, HHI 247
- Coloplast Corp : $3.4M total payments, HHI 246
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Olympus Medical Systems Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Olympus Medical Systems Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Olympus Medical Systems Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
SCYNEXIS, Inc.
$244.8K 0 recipients
Compare payment profiles
Embecta Corp.
$245.4K 713 recipients
Compare payment profiles
Vivus LLC
$245.5K 3,639 recipients
Compare payment profiles
Total Joint Orthopedics, Inc.
$245.5K 360 recipients
Compare payment profiles
Nico Corporation
$245.7K 49 recipients
Compare payment profiles
Put this to use
Olympus Medical Systems Corporation ranks #950 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Olympus Medical Systems Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.